[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"nutrition-intake\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:nutrition-intake":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,43],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100626613","a-randomized-triple-blind-placebo-controlled-study-to-evaluate-the-effects-of-a-supplement-on-nutrient-gaps-and-gut-health-among-individuals-utilizing-glp-1-ras-100626613",false,"NCT07437911","A Randomized, Triple-blind, Placebo-controlled Study to Evaluate the Effects of a Supplement on Nutrient Gaps and Gut Health Among Individuals Utilizing GLP-1 RAs","Inclusion Criteria:\n\n* Be male or female\n* Be aged 18-59.\n* Has a BMI between 20-31.9.\n* Anyone currently taking GLP-1 medication at their maintenance dose (week 8+), and without any plans to alter their dosage. This includes: Semaglutide (Ozempic®, Wegovy®, Rybelsus®), Liraglutide (Saxenda®, Victoza®), Dulaglutide (Trulicity®), Exenatide (Byetta®, Bydureon®), Lixisenatide (Adlyxin®)\n* Anyone willing to follow the study protocol, including immediately prior to the all blood tests, duplicating their diet for 72 hours (3 days), refraining from caffeine and exercise for 24 hours, and fasting for 10 hours.\n* Anyone willing to maintain their current diet, sleep pattern, and activity levels for the duration of the trial.\n* Anyone willing to avoid introducing any other supplements, medications, or herbal remedies for the duration of this trial.\n* Anyone who is generally healthy - does not live with any diagnosed uncontrolled chronic disease.\n* Has access to a consistent weighing scale for the duration of the study.\n* Resides in the United States.\n\nExclusion Criteria:\n\n* Anyone with a diagnosis of Type I or Type II diabetes.\n* Anyone with a diagnosis of any metabolic health condition, such as hypertension and dyslipidemia.\n* Anyone who has taken any multivitamin\u002Fmultimineral supplements within the past 3 months.\n* Anyone who has taken a probiotic supplement within the past month.\n* Anyone who has regularly consumed (5 days\u002Fweek or more) products that target healthy aging, anti-aging, longevity, gut health, energy, or ingestive behaviour (such as cravings), including resveratrol, quercetin, pterostilbene, coQ10, grapefruit, nicotinamide riboside, prebiotic fiber, green tea, niacin (vitamin B3) within the past 2 months.\n* Anyone who has received an antibiotic, antifungal, antiparasitic, or antiviral treatment within the past 90 days.\n* Anyone who has a known history of severe digestive disorders or metabolic conditions that impact nutrient absorption or metabolism, including acid reflux, Irritable Bowel Syndrome (IBS), Irritable Bowel Disease (IBD), Crohn's disease, a history of colon resection, gastroparesis, Inborn errors of metabolism (such as PKU), or gastrointestinal tract surgeries.\n* Anyone with any known allergies or hypersensitivities to any supplement product ingredients.\n* Anyone with any chronic health conditions that could impact participation in this study, such as asthma, gout, fibromyalgia, chronic inflammatory conditions (such as Crohn's, Lupus, HIV\u002FAIDS), thyroid conditions, cancer (within the past 5 years), mental health disorders, history of serious illness in the last three months, history of substance abuse, or planned surgery during the study period.\n* Anyone currently pregnant, trying to conceive, or breastfeeding.\n* Anyone who has undergone a change in hormone therapy (including oral contraceptives) within the past 4 weeks, or is unwilling to maintain their current hormone therapy\u002Foral contraceptive use throughout the course of the study.\n* Anyone who consumes more than 2 standard alcoholic drinks per day or more than 10 drinks per week, or has within the past 6 months.\n* Anyone who is currently a smoker or has been a smoker within the past month.\n* Anyone who follows a specific exclusion diet, including vegan, vegetarian, carnivore, paleo, atkins, or ketogenic.","ALL","18 Years","59 Years",{"count":19,"type":20},120,"ESTIMATED","INTERVENTIONAL",[23],"NA","This study is a triple-blind, placebo-controlled, randomized controlled trial of 120 adults that will evaluate the impact of a novel nutritional supplement on improving nutrient gaps and changing nutrient status and the gut microbiome among glucagon-like peptide-1 receptor agonist (GLP-1 RA) users.",[26,27,28,29],"Nutrition Intake","Nutrition Status","Gastrointestinal Microbiome","GLP-1","RECRUITING","2026-02-24",{"date":33,"type":34},"2026-02-27","ACTUAL",{"date":36,"type":20},"2026-02",{"date":38,"type":20},"2026-08",{"name":40,"class":41},"Athletic Greens International","INDUSTRY",1,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":51,"targetDuration":4,"studyType":21,"phases":53,"briefSummary":54,"conditions":55,"keywords":58,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":67,"completionDateStruct":68,"leadSponsor":70,"locationsCount":42},"100604417","the-effect-of-a-6-month-dietitian-tailored-nutrition-intervention-to-patients-with-critical-illness-detail-100604417","NCT07149246","The Effect of a 6-month Dietitian-tailored Nutrition Intervention to Patients With Critical Illness (DETAIL)","The Effect of a 6-month DiEtitian-TAILored Nutrition Intervention Compared to Usual Care in Patients With Critical Illness. A Single Center Prospective Intervention Study","DETAIL","Inclusion Criteria: Patients in intensive care who gives an informed consent and meet all of the following will be eligible:\n\n1. Admitted to the intensive care unit for \\>48 hours.\n2. At least 18 years of age\n3. Have one or more organ system failure (respiratory,cardiovascular or renal) related to their acute illness defined as:\n\n   a. PaO2\u002FFiO2≤300 mm Hg) b. Currently on one or more continuous inotrope\u002Fvasopressor infusion which were started at least 4 hours ago at a minimum dose of: i. Norepinephrine≥0.1 mcg\u002Fkg\u002Fmin ii. Epinephrine≥0.1 mcg\u002Fkg\u002Fmin iii. Any dose of vasopressin iv. Milrinone\\>0.1 mcg\u002Fkg\u002Fmin) c. Renal dysfunction defined as: i. Serum creatinine 2.0-2.9 times baseline or ii. Urine output 0.5 mL\u002Fkg\u002Fhour for ≥12 hours or iii. Currently receiving renal replacement therapy) d. Currently has an intracranial pressure monitor or ventricular drain in situ\n4. Permanent living address in Norway\n\nExclusion Criteria: Patients will be excluded if:\n\n1. Death is imminent in the next 96 hours or there is a current treatment limitation in place or the patient is unlikely to survive to 180 days due to underlying\u002Fchronic illness\n2. Dialysis dependent chronic renal failure\n3. Suspected or known pregnancy\n4. Wheelchair user\n5. Cognitive impairment in which intervention is considered not appropriate\n6. Eating disorders -",{"count":52,"type":20},300,[23],"This research project aims to study the effect of optimal and individualised nutrition to patients with critical illness during the intensive care unit (ICU) and hospital admission, and until six months after admission. The investigators want to describe and compare the usual care with a dietitian-tailored nutrition care. The hypothesis is that dietitian-tailored nutrition care will result in a higher mean energy intake compared to usual care.",[56,26,57],"ICU Patients","Critical Illness",[59,60,61,62,63],"Nutrition","Energy intake","Protein intake","ICU","Dietitian","2025-09-01",{"date":66,"type":34},"2025-09-03",{"date":64,"type":34},{"date":69,"type":20},"2028-03-31",{"name":71,"class":72},"University Hospital of North Norway","OTHER"]